Study at a glance
How can vitamin D activity raise blood calcium too high?
This page summarises how excessive vitamin D activity can cause hypercalcaemia, meaning too much calcium in blood. Vitamin D helps the intestine absorb calcium. When this activity becomes excessive, the body may be unable to keep calcium balanced. Taking too much vitamin D is one possible cause, but there are others.
What can cause excessive vitamin D activity?
Very large, sustained amounts of vitamin D2 or D3 can produce extremely high levels on the usual vitamin D blood test. Active vitamin D medicines can raise calcium without that same test pattern. Certain diseases can also cause excess production of active vitamin D. Another cause is failure of CYP24A1, an enzyme that normally helps break vitamin D down.
How does the body respond to rising blood calcium?
As blood calcium rises, parathyroid hormone, which helps regulate calcium, normally falls. The kidneys remove more calcium through urine. Too much calcium in urine may appear before blood calcium stays high. It can contribute to kidney stones and calcium deposits in kidney tissue. Excessive vitamin D activity can also interfere with the kidneys’ ability to concentrate urine.
Can one vitamin D blood result establish toxicity?
No single vitamin D level causes high blood calcium in everyone. A very high result is a reason for concern, but the result alone does not establish toxicity. Calcium, parathyroid hormone, kidney function and the type of vitamin D exposure also matter. Different causes of excessive vitamin D activity can produce different blood-test patterns.
Read the full article below ↓Vitamin D-induced hypercalcaemia occurs when vitamin D-mediated calcium activity becomes strong enough to overwhelm normal mineral-homeostasis mechanisms. Excessive vitamin D intake is one cause, but it is not the only one. Excessive extrarenal production of active vitamin D and impaired CYP24A1-dependent degradation can produce similar calcium dysregulation through different biochemical routes. For the complete evidence treatment, see Vitamin D-Induced Hypercalcaemia: Mechanisms of Calcium Dysregulation: Full Study.
Why vitamin D can raise calcium
Active vitamin D signalling increases intestinal calcium absorption and participates in renal and skeletal calcium regulation. Under normal conditions this is part of Vitamin D and Calcium Physiology. When vitamin D activity becomes excessive, more calcium can enter the circulation than the body’s compensatory systems can comfortably handle.
PTH is normally suppressed as calcium rises, while the kidneys increase calcium excretion. Hypercalciuria may therefore accompany or precede sustained hypercalcaemia.
Excess supplementation is one mechanism
Very large and sustained exposure to vitamin D₂ or vitamin D₃ can produce extremely high 25(OH)D concentrations. At supraphysiological concentrations, vitamin D metabolites can drive excessive receptor-mediated calcium activity. This is the classic pattern of exogenous vitamin D intoxication.
Direct exposure to calcitriol or active vitamin D analogues is different. Because these compounds act farther downstream in the pathway, hypercalcaemia can develop without an extreme 25(OH)D concentration.
Failure of degradation can produce the same endpoint
CYP24A1 normally helps inactivate 25(OH)D and 1,25(OH)₂D. Pathogenic loss of CYP24A1 function can therefore allow vitamin D metabolites to persist abnormally, producing hypercalcaemia, hypercalciuria, kidney stones or nephrocalcinosis even when excessive supplementation is not the underlying cause.
This is why Vitamin D Clearance and Degradation is central to understanding toxicity physiology. An excessive effect can arise because too much vitamin D enters the pathway or because the pathway cannot switch the signal off normally.
Granulomatous disease can generate excessive active hormone
Activated macrophages in diseases such as sarcoidosis or tuberculosis can express CYP27B1 and produce 1,25(OH)₂D outside normal renal regulation. Some lymphomas can produce a similar calcitriol-mediated pattern. In these settings the problem is excessive active-hormone production rather than simple oral vitamin D overdose.
The laboratory pattern depends on the mechanism
Classic vitamin D₂ or vitamin D₃ intoxication usually produces a very high 25(OH)D concentration. Granulomatous and lymphoma-associated hypercalcaemia may instead show elevated or inappropriate 1,25(OH)₂D. CYP24A1 deficiency can show impaired 24-hydroxylation and persistent active-vitamin-D effects.
The renal consequences are important enough to connect this mechanism directly with Vitamin D and Kidneys. Hypercalciuria, nephrolithiasis, nephrocalcinosis and impaired concentrating ability can all become part of the clinical picture.
A high vitamin D result is not automatically toxicity
No single 25(OH)D concentration produces hypercalcaemia in every person. Very high concentrations increase concern, but toxicity is a physiological syndrome involving calcium dysregulation rather than a laboratory label based on 25(OH)D alone.
The evidence therefore supports interpreting upper-range values in the same disciplined way discussed in Vitamin D Thresholds vs Targets: the number matters, but calcium, PTH, exposure history, kidney function and the mechanism producing the result matter too.
Primary scientific sources and publication details
Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocrine Reviews. 2016;37(5):521-547. PMID: 27588937. PMCID: PMC5045493. DOI: 10.1210/er.2016-1070.
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13-31. PMID: 23564710. PMCID: PMC3927478. DOI: 10.1194/jlr.R031534.
Schlingmann KP. Vitamin D-dependent Hypercalcemia. Endocrinology and Metabolism Clinics of North America. 2021;50(4):729-742. PMID: 34774244. DOI: 10.1016/j.ecl.2021.08.005.
Related reading
Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients
These patients were compared to a historical control group that underwent therapy with a higher target of >29.9 ng/mL.
Original paper ↗Read more →Vitamin D-Induced Hypercalcaemia: Mechanisms of Calcium Dysregulation: Full Study
AA full evidence review of how excess vitamin D activity, extrarenal calcitriol production and impaired CYP24A1 clearance can cause hypercalcaemia.
Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study
Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals.
Original paper ↗Read more →Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk
The present study investigated Ca absorption patterns with increasing levels of fortification in milk, and the response to one dose of a Ca salt.
Original paper ↗Read more →Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
Bone health of the elderly is a major global health concern, since about 1 in 3 women and 1 in 5 men suffer from bone loss and fractures, often called osteoporosis, in old age.
Original paper ↗Read more →Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study
A total of 4080 participants were recruited.
Original paper ↗Read more →Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure
Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease (CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear.
Original paper ↗Read more →Effect of dietary Ca:P ratio on ionized calcium and calcium homeostasis in cats with early-stage chronic kidney disease
The aim of the study was to compare two renal foods with different Ca:P ratios on manifestation of hypercalcemia and regulation of calcium homeostasis in cats with chronic kidney disease (CKD).
Original paper ↗Read more →Status of vitamin D and parameters of calcium homeostasis in renal transplant recipients in Nepal: a cross sectional study
This study aimed to determine the prevalence of hypovitaminosis D in Nepalese RTRs and interrelations between serum 25-hydroxyvitamin D [25(OH) D] and other biochemical parameters.
Original paper ↗Read more →The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis: clinical practice recommendation from the Pediatric Renal Nutrition Taskforce
Complications of mineral bone disease (MBD) are common and contribute to the high morbidity and mortality seen in children with CKD.
Original paper ↗Read more →Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D
We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
However, evidence of the causal role of mineral metabolism in CAVS is still lacking.
Original paper ↗Read more →Interactions between Vitamin D Status, Calcium Intake and Parathyroid Hormone Concentrations in Healthy White-Skinned Pregnant Women at Northern Latitude
Little explored in pregnancy, we aimed to examine the relative importance of serum 25-hydroxyvitamin D (25(OH)D) and calcium intake on parathyroid hormone (PTH) concentrations in healthy white-skinned pregnant women.
Original paper ↗Read more →R990G Polymorphism of Calcium Sensing Receptor Gene Is Associated with High Parathyroid Hormone Levels in Subjects with Vitamin D Deficiency: A Cross-Sectional Study
Single nucleotide polymorphisms (SNPs), R990G and A986S of the calcium sensing receptor (CaSR) gene, are shown to influence response of parathyroid hormone (PTH) in subjects with optimal vitamin D levels.
Original paper ↗Read more →The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
Background and objectives: Vitamin D is an essential vitamin that plays a key role in maintaining physiological calcium balance, and is also a pivotal element in the formation of bone structure.
Original paper ↗Read more →Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.
Original paper ↗Read more →Parathyroid histology in normocalcemic and hypercalcemic primary hyperparathyroidism with hypercalciuric renal stones
This study aimed to compare the histological features of NHPT and HPHPT parathyroid glands, but also rims of normal tissue, focusing on the expression of calcium-sensing receptor (CaSR), 1-α hydroxylase (CYP27B1), and vitamin D receptor (VDR).
Original paper ↗Read more →Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1 to 34) analogs in women
After propensity score matching (n = 2,258 pairs), ROMO users had lower risks of osteoporotic fractures (HR: 0.711, 95% CI: 0.542 to 0.931) and hypercalcemia (HR = 0.707, 95% CI: 0.511 to 0.977) compared with PTH receptor agonists.
Original paper ↗Read more →Vitamin D Homeostasis Mechanisms
Vitamin D homeostasis is the body’s system for regulating vitamin D activation, storage, transport, and breakdown.
Read more →Original sources
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Published in Endocrine Reviews (2016).
Publication details
Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocrine Reviews. 2016;37(5):521-547. PMID: 27588937. PMCID: PMC5045493. DOI: 10.1210/er.2016-1070.
Cytochrome P450-mediated metabolism of vitamin D
Published in Journal of Lipid Research (2014).
Publication details
Jones G, Prosser DE, Kaufmann M. Cytochrome P450-mediated metabolism of vitamin D. Journal of Lipid Research. 2014;55(1):13-31. PMID: 23564710. PMCID: PMC3927478. DOI: 10.1194/jlr.R031534.
Vitamin D-dependent Hypercalcemia
Published in Endocrinology and Metabolism Clinics of North America (2021).
Publication details
Schlingmann KP. Vitamin D-dependent Hypercalcemia. Endocrinology and Metabolism Clinics of North America. 2021;50(4):729-742. PMID: 34774244. DOI: 10.1016/j.ecl.2021.08.005.